Other studies reported insufficient anti-viral T cell responses in long COVID patients, including lower abundance of nucleocapsid-specific CD8+ T cells expressing CD107a (a degranulation marker) at 4 months post infection [40] and reduced or absent SARS-CoV-2-specific CD4+ and CD8+ T cells in severe long COVID [32]. Here, CD8A is linked to infection.